Prognostic Significance of Circulating Lymphocyte Subsets Before Treatment in Patients with Nasopharyngeal Carcinoma.

De-Song ShenChang YanYu LiangKai-Hua ChenXiao-Dong Zhu

Published in: Cancer management and research (2021)

NPC patients with low levels of CD19+ B cells or CD4+ T cells before treatment have a poor prognosis. In addition, chemoradiotherapy may reduce the body's immune function in NPC patients.

Keyphrases

poor prognosis
end stage renal disease
long non coding rna
chronic kidney disease
newly diagnosed
peripheral blood
peritoneal dialysis
prognostic factors
squamous cell carcinoma
radiation therapy
rectal cancer
patient reported outcomes